Log in to save to my catalogue

Structural basis of TRPV1 inhibition by SAF312 and cholesterol

Structural basis of TRPV1 inhibition by SAF312 and cholesterol

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_76f10ec5075d4ea089d0013dab1fd995

Structural basis of TRPV1 inhibition by SAF312 and cholesterol

About this item

Full title

Structural basis of TRPV1 inhibition by SAF312 and cholesterol

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2024-08, Vol.15 (1), p.6689-9, Article 6689

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Transient Receptor Potential Vanilloid 1 (TRPV1) plays a central role in pain sensation and is thus an attractive pharmacological drug target. SAF312 is a potent, selective, and non-competitive antagonist of TRPV1 and shows promising potential in treating ocular surface pain. However, the precise mechanism by which SAF312 inhibits TRPV1 remains poo...

Alternative Titles

Full title

Structural basis of TRPV1 inhibition by SAF312 and cholesterol

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_76f10ec5075d4ea089d0013dab1fd995

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_76f10ec5075d4ea089d0013dab1fd995

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-024-51085-3

How to access this item